Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Paxlovid Meta
Famotidine Meta Quercetin Meta
Favipiravir Meta Remdesivir Meta
Fluvoxamine Meta Thermotherapy Meta
Hydroxychlor.. Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Vitamin D concentrations and COVID-19 infection in UK Biobank

Hastie et al., Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14:4, 561–565, doi:10.1016/j.dsx.2020.04.050
Aug 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 17% Improvement Relative Risk Hospitalization 9% Vitamin D for COVID-19  Hastie et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 341,484 patients in the United Kingdom Lower mortality with higher vitamin D levels (not stat. sig., p=0.31) c19early.org Hastie et al., Diabetes and Metabolic .., Aug 2020 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now with p < 0.00000000001 from 122 studies, recognized in 9 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,400+ studies for 79 treatments. c19early.org
Database analysis of 341,484 patients in the UK with 656 hospitalized confirmed COVID-19 patients and 203 deaths, not showing a statistically significant difference after adjustment. Since adjustment factors may be correlated with vitamin D deficiency, the extent of any causal contribution of both vitamin D and the adjustment factors is unclear.
There was an ~10 year time period between baseline 25(OH)D measurement and COVID-19 infection, with 84% concordance for a subsample with measurements ~4.3 years later. Vitamin D levels may change significantly across seasons and years. People that discovered they had low vitamin D levels may have been encouraged to take steps to correct the deficiency.
Davies et al. raise a number of concerns with this study1, reporting that it lacked power, suffered low precision and high bias, used flawed models, and contained many serious statistical errors. 1. Mislabelled data artificially inflated the control set, creating an illusion of high power & precision in an underpowered data set study, 2. Logistic regression violated multiple prerequisite conditions, creating biased results and a further reduction of power (overfit, over-adjusted, poor variable types, and poor handling), and 3. Unreliable data in the logistic regressions caused regression dilution bias, bias amplification, and further loss of power and precision.
See also2.
This is the 11th of 199 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 835,162 vigintillion).
risk of death, 17.4% lower, RR 0.83, p = 0.31, cutoff 25nmol/L, adjusted per study, inverted to make RR<1 favor high D levels (≥25nmol/L), multivariable Cox.
risk of hospitalization, 9.1% lower, RR 0.91, p = 0.40, cutoff 25nmol/L, adjusted per study, inverted to make RR<1 favor high D levels (≥25nmol/L), multivariable Cox.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Hastie et al., 26 Aug 2020, retrospective, population-based cohort, database analysis, United Kingdom, peer-reviewed, 14 authors.
This PaperVitamin DAll
Vitamin D and COVID-19 infection and mortality in UK Biobank
Claire E Hastie, Jill P Pell, Naveed Sattar
European Journal of Nutrition, doi:10.1007/s00394-020-02372-4
Purpose Low blood 25-hydroxyvitamin D (25(OH)D) concentration has been proposed as a potential causal factor in COVID-19 risk. We aimed to establish whether baseline serum 25(OH)D concentration was associated with COVID-19 mortality, and inpatient confirmed COVID-19 infection, in UK Biobank participants. Methods UK Biobank recruited 502,624 participants aged 37-73 years between 2006 and 2010. Baseline exposure data, including serum 25(OH)D concentration, were linked to COVID-19 mortality. Univariable and multivariable Cox proportional hazards regression analyses were performed for the association between 25(OH)D and COVID-19 death, and Poisson regression analyses for the association between 25(OH)D and severe COVID-19 infection. Results Complete data were available for 341,484 UK Biobank participants, of which 656 had inpatient confirmed COVID-19 infection and 203 died of COVID-19 infection. 25(OH)D concentration was associated with severe COVID-19 infection and mortality univariably (mortality per 10 nmol/L 25(OH)D HR 0.92; 95% CI 0.86-0.98; p = 0.016), but not after adjustment for confounders (mortality per 10 nmol/L 25(OH)D HR 0.98; 95% CI = 0.91-1.06; p = 0.696). Vitamin D insufficiency or deficiency was also not independently associated with either COVID-19 infection or linked mortality. Conclusions Our findings do not support a potential link between 25(OH)D concentrations and risk of severe COVID-19 infection and mortality. Randomised trials are needed to prove a beneficial role for vitamin D in the prevention of severe COVID-19 reactions or death.
Conflict of interest The authors declare that they have no conflict of interest. Ethics approval UK Biobank received ethical approval from the North West Multi-Centre Research Ethics Committee (REC reference: 16/ NW/0274) and was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent All participants gave written informed consent for data collection, analysis, and record linkage. All participants gave written informed consent for publication of research. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
Hastie, Mackay, Ho, Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr Clin Res Rev, doi:10.1016/j.dsx.2020.04.050
Mitchell, Vitamin-D and COVID-19: do deficient risk a poorer outcome?, Lancet Diabetes Endocrinol, doi:10.1016/S2213-8587(20)30183-2
Nhs, Vitamins and minerals: Vitamin D
Nice, COVID-19 rapid evidence summary:vitamin D for COVID-19
Raisi-Estabragh, Mccracken, Bethell, Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank, doi:10.1093/pubmed/fdaa095
Sattar, Welsh, Panarelli, Forouhi, Increasing requests for vitamin D measurement: costly, confusing, and without credibility, Lancet, doi:10.1016/S0140-6736(11)61816-3
{ 'indexed': {'date-parts': [[2024, 4, 8]], 'date-time': '2024-04-08T09:11:34Z', 'timestamp': 1712567494519}, 'reference-count': 27, 'publisher': 'Elsevier BV', 'issue': '4', 'license': [ { 'start': { 'date-parts': [[2020, 7, 1]], 'date-time': '2020-07-01T00:00:00Z', 'timestamp': 1593561600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'funder': [ {'name': 'Health Data Research-UK'}, {'name': 'NRS Senior Clinical Fellowship', 'award': ['SCAF/15/02']}, { 'DOI': '10.13039/501100000265', 'name': 'Medical Research Council', 'doi-asserted-by': 'publisher', 'award': ['MC_UU_12017/13']}, { 'DOI': '10.13039/501100000589', 'name': 'Scottish Government Chief Scientist Office', 'doi-asserted-by': 'publisher', 'award': ['SPHSU13']}, { 'DOI': '10.13039/501100000265', 'name': 'Medical Research Council', 'doi-asserted-by': 'publisher', 'award': ['MR/R024774/1']}, { 'DOI': '10.13039/501100000274', 'name': 'British Heart Foundation Research Excellence Award', 'doi-asserted-by': 'publisher', 'award': ['RE/18/6/34217']}], 'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.fr', 'clinicalkey.com.au', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2020, 7]]}, 'DOI': '10.1016/j.dsx.2020.04.050', 'type': 'journal-article', 'created': {'date-parts': [[2020, 5, 7]], 'date-time': '2020-05-07T16:04:07Z', 'timestamp': 1588867447000}, 'page': '561-565', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 342, 'title': 'Vitamin D concentrations and COVID-19 infection in UK Biobank', 'prefix': '10.1016', 'volume': '14', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-4604-3319', 'authenticated-orcid': False, 'given': 'Claire E.', 'family': 'Hastie', 'sequence': 'first', 'affiliation': []}, {'given': 'Daniel F.', 'family': 'Mackay', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-7190-9025', 'authenticated-orcid': False, 'given': 'Frederick', 'family': 'Ho', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carlos A.', 'family': 'Celis-Morales', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-6593-9092', 'authenticated-orcid': False, 'given': 'Srinivasa Vittal', 'family': 'Katikireddi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Claire L.', 'family': 'Niedzwiedz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bhautesh D.', 'family': 'Jani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul', 'family': 'Welsh', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-9780-1135', 'authenticated-orcid': False, 'given': 'Frances S.', 'family': 'Mair', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stuart R.', 'family': 'Gray', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-5368-3779', 'authenticated-orcid': False, 'given': 'Catherine A.', 'family': 'O’Donnell', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-3615-0986', 'authenticated-orcid': False, 'given': 'Jason MR.', 'family': 'Gill', 'sequence': 'additional', 'affiliation': []}, {'given': 'Naveed', 'family': 'Sattar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jill P.', 'family': 'Pell', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.dsx.2020.04.050_bib1', 'series-title': 'Covid-19 study case mix programme', 'author': 'Intensive Care National Audit and Research Centre', 'year': '2020'}, {'key': '10.1016/j.dsx.2020.04.050_bib2', 'author': 'Office for National Statistics'}, { 'key': '10.1016/j.dsx.2020.04.050_bib3', 'author': 'John Hopkins Coronavirus Resource Centre'}, { 'key': '10.1016/j.dsx.2020.04.050_bib4', 'doi-asserted-by': 'crossref', 'first-page': 'm1548', 'DOI': '10.1136/bmj.m1548', 'article-title': 'Is ethnicity linked to incidence or outcomes of covid-19?', 'volume': '369', 'author': 'Khunti', 'year': '2020', 'journal-title': 'BMJ'}, {'key': '10.1016/j.dsx.2020.04.050_bib5', 'author': 'UK Government'}, { 'key': '10.1016/j.dsx.2020.04.050_bib6', 'doi-asserted-by': 'crossref', 'first-page': '11', 'DOI': '10.1016/j.atherosclerosissup.2006.01.003', 'article-title': 'CVD risk factors and ethnicity–a homogeneous relationship?', 'volume': '7', 'author': 'Forouhi', 'year': '2006', 'journal-title': 'Atherosclerosis Suppl'}, { 'key': '10.1016/j.dsx.2020.04.050_bib7', 'article-title': 'Factors associated with hospitalization and critical illness among ' '4,103 patients with COVID-19 disease in New York City', 'author': 'Petrilli', 'year': '2020', 'journal-title': 'medRxiv'}, { 'key': '10.1016/j.dsx.2020.04.050_bib8', 'article-title': 'The epidemiological and clinical features of COVID-19 and lessons from ' 'this global infectious public health event', 'author': 'Tu', 'year': '2020', 'journal-title': 'J\xa0Infect'}, { 'key': '10.1016/j.dsx.2020.04.050_bib9', 'doi-asserted-by': 'crossref', 'first-page': 'g2035', 'DOI': '10.1136/bmj.g2035', 'article-title': 'Vitamin D and multiple health outcomes: umbrella review of systematic ' 'reviews and meta-analyses of observational studies and randomised ' 'trials', 'volume': '348', 'author': 'Theodoratou', 'year': '2014', 'journal-title': 'BMJ'}, { 'key': '10.1016/j.dsx.2020.04.050_bib10', 'first-page': '118', 'article-title': 'The "sunshine" vitamin', 'volume': '3', 'author': 'Nair', 'year': '2012', 'journal-title': 'J\xa0Pharmacol Pharmacother'}, { 'key': '10.1016/j.dsx.2020.04.050_bib11', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.3310/hta23020', 'article-title': 'Vitamin D supplementation to prevent acute respiratory infections: ' 'individual participant data meta-analysis', 'volume': '23', 'author': 'Martineau', 'year': '2019', 'journal-title': 'Health Technol Assess'}, { 'key': '10.1016/j.dsx.2020.04.050_bib12', 'doi-asserted-by': 'crossref', 'first-page': '1173', 'DOI': '10.1016/S0140-6736(12)60404-8', 'article-title': 'What makes UK Biobank special?', 'volume': '379', 'author': 'Collins', 'year': '2012', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.dsx.2020.04.050_bib13', 'doi-asserted-by': 'crossref', 'first-page': 'e1001779', 'DOI': '10.1371/journal.pmed.1001779', 'article-title': 'UK biobank: an open access resource for identifying the causes of a ' 'wide range of complex diseases of middle and old age', 'volume': '12', 'author': 'Sudlow', 'year': '2015', 'journal-title': 'PLoS Med'}, { 'key': '10.1016/j.dsx.2020.04.050_bib14', 'series-title': 'Dynamic linkage of COVID-19 test results between Public Health England’s ' 'Second Generation Surveillance System and UK Biobank', 'author': 'Armstrong', 'year': '2020'}, { 'key': '10.1016/j.dsx.2020.04.050_bib15', 'doi-asserted-by': 'crossref', 'first-page': '234', 'DOI': '10.1093/ije/dym276', 'article-title': 'Biobank UK. The UK Biobank sample handling and storage protocol for the ' 'collection, processing and archiving of human blood and urine', 'volume': '37', 'author': 'Elliott', 'year': '2008', 'journal-title': 'Int J Epidemiol'}, { 'key': '10.1016/j.dsx.2020.04.050_bib17', 'series-title': 'Health and deprivation: inequality and the North', 'author': 'Townsend', 'year': '1987'}, { 'key': '10.1016/j.dsx.2020.04.050_bib18', 'doi-asserted-by': 'crossref', 'first-page': 'i6201', 'DOI': '10.1136/bmj.i6201', 'article-title': 'Should adults take vitamin D supplements to prevent disease?', 'volume': '355', 'author': 'Bolland', 'year': '2016', 'journal-title': 'BMJ'}, { 'key': '10.1016/j.dsx.2020.04.050_bib19', 'doi-asserted-by': 'crossref', 'DOI': '10.1007/s40615-020-00756-0', 'article-title': 'The COVID-19 pandemic: a call to action to identify and address racial ' 'and ethnic disparities', 'author': 'Laurencin', 'year': '2020', 'journal-title': 'J\xa0Racial Ethn Health Disparities'}, { 'key': '10.1016/j.dsx.2020.04.050_bib20', 'doi-asserted-by': 'crossref', 'first-page': 'E589', 'DOI': '10.1152/ajpendo.00138.2020', 'article-title': 'COVID-19 and vitamin D-Is there a link and an opportunity for ' 'intervention?', 'volume': '318', 'author': 'Jakovac', 'year': '2020', 'journal-title': 'Am J Physiol Endocrinol Metab'}, { 'key': '10.1016/j.dsx.2020.04.050_bib21', 'first-page': '12', 'article-title': 'Evidence that vitamin D supplementation could reduce risk of influenza ' 'and COVID-19 infections and deaths', 'author': 'Grant', 'year': '2020', 'journal-title': 'Nutrients'}, { 'key': '10.1016/j.dsx.2020.04.050_bib22', 'article-title': 'Editorial: low population mortality from COVID-19 in countries south of ' 'latitude 35 degrees North - supports vitamin D as a factor determining ' 'severity', 'author': 'Rhodes', 'year': '2020', 'journal-title': 'Aliment Pharmacol Ther'}, { 'key': '10.1016/j.dsx.2020.04.050_bib23', 'doi-asserted-by': 'crossref', 'DOI': '10.1161/CIRCULATIONAHA.120.047659', 'article-title': 'Obesity a risk factor for severe COVID-19 infection: multiple potential ' 'mechanisms', 'author': 'Sattar', 'year': '2020', 'journal-title': 'Circulation'}, { 'key': '10.1016/j.dsx.2020.04.050_bib24', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jama.2020.6775', 'article-title': 'Presenting Characteristics, comorbidities, and outcomes among 5700 ' 'patients hospitalized with COVID-19 in the New York city area', 'author': 'Richardson', 'year': '2020', 'journal-title': 'J\xa0Am Med Assoc'}, { 'key': '10.1016/j.dsx.2020.04.050_bib25', 'article-title': 'Analysis of factors associated with disease outcomes in hospitalized ' 'patients with 2019 novel coronavirus disease', 'author': 'Liu', 'year': '2020', 'journal-title': 'Chin Med J (Engl)'}, { 'key': '10.1016/j.dsx.2020.04.050_bib26', 'article-title': 'Low incidence of daily active tobacco smoking in patients with ' 'symptomatic COVID-19', 'author': 'Miyara', 'year': '2020', 'journal-title': 'Qeios'}, { 'key': '10.1016/j.dsx.2020.04.050_bib27', 'doi-asserted-by': 'crossref', 'first-page': '1026', 'DOI': '10.1093/aje/kwx246', 'article-title': 'Comparison of sociodemographic and health-related Characteristics of UK ' 'biobank participants with those of the general population', 'volume': '186', 'author': 'Fry', 'year': '2017', 'journal-title': 'Am J Epidemiol'}, { 'key': '10.1016/j.dsx.2020.04.050_bib28', 'doi-asserted-by': 'crossref', 'first-page': '916', 'DOI': '10.1158/1055-9965.EPI-12-0026', 'article-title': 'Intraindividual variation in plasma 25-hydroxyvitamin D measures 5 ' 'years apart among postmenopausal women', 'volume': '21', 'author': 'Meng', 'year': '2012', 'journal-title': 'Canc Epidemiol Biomarkers Prev'}], 'container-title': 'Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1871402120301156?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1871402120301156?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2021, 9, 28]], 'date-time': '2021-09-28T10:12:29Z', 'timestamp': 1632823949000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1871402120301156'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 7]]}, 'references-count': 27, 'journal-issue': {'issue': '4', 'published-print': {'date-parts': [[2020, 7]]}}, 'alternative-id': ['S1871402120301156'], 'URL': 'http://dx.doi.org/10.1016/j.dsx.2020.04.050', 'relation': {}, 'ISSN': ['1871-4021'], 'subject': ['General Medicine', 'Endocrinology, Diabetes and Metabolism', 'Internal Medicine'], 'container-title-short': 'Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews', 'published': {'date-parts': [[2020, 7]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Vitamin D concentrations and COVID-19 infection in UK Biobank', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'Diabetes & Metabolic Syndrome: Clinical Research & Reviews', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.dsx.2020.04.050', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.', 'name': 'copyright', 'label': 'Copyright'}]}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit